Get started
Author

Гречкина Виолетта Владимировна

Observed names: V. V. Bader, V. V. Grechkina, Violetta V. Bader, Violetta V. Grechkina
ORCID: 0000-0001-8279-4198
Observed ORCID: 0000-0001-8279-4198
OpenAlex ID: A5029725577
Therapeutic and Toxic Effects of Valproic Acid Metabolites
2023 · Natalia A. Shnayder, Violetta V. Grechkina, et al. · Metabolites · 93
PDF
Valproate-Induced Metabolic Syndrome
2023 · Natalia A. Shnayder, Violetta V. Grechkina, et al. · Biomedicines · 25
PDF
Frequency of "Poor Transporter" Phenotype Among Patients with Mental Disorders: Pilot Study
2024 · I. R. Boyko, N. A. Shnayder, et al. · Personalized Psychiatry and Neurology · 8
PDF
Personalized approach to prediction and prevention of haloperidol-induced QT interval prolongation: brief review
2024 · R. F. Nasyrova, A. V. Kidyaeva, et al. · Pharmacogenetics and Pharmacogenomics · 8
The role of microRNAs as regulators of systemic inflammatory response in anticonvulsant-induced metabolic syndrome
2025 · N. A. Shnayder, N. A. Pekarets, et al. · Epilepsy and Paroxysmal Conditions · 7
Role of neuropeptide Y in development of valproate-induced eating behaviour disorder
2025 · N. A. Shnayder, V. V. Grechkina, et al. · Epilepsy and Paroxysmal Conditions · 7
PDF
Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid
2023 · N. A. Shnayder, V. V. Grechkina, et al. · Safety and Risk of Pharmacotherapy · 7
PDF
Personalized Approach to Prediction and Prevention Clozapine-Induced QT Prolongation
2025 · R. F. Nasyrova, A. V. Kidyaeva, et al. · Psikhiatriya · 5
PDF
Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
2024 · N. A. Shnayder, V. V. Grechkina, et al. · Safety and Risk of Pharmacotherapy · 5
Ethnic Aspects of Valproic Acid P-Oxidation
2024 · Natalia A. Shnayder, Violetta V. Grechkina, et al. · Biomedicines · 4
Circulating MicroRNAs Are Promising Biomarkers for Assessing the Risk of Antipsychotic-Induced Metabolic Syndrome (Review): Part 2
2025 · N. A. Shnayder, R. F. Nasyrova, et al. · Safety and Risk of Pharmacotherapy · 2
Circulating MicroRNAs Are Promising Biomarkers for Assessing the Risk of Antipsychotic-Induced Metabolic Syndrome (Review): Part 1
2025 · N. A. Shnayder, R. F. Nasyrova, et al. · Safety and Risk of Pharmacotherapy · 2
MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review
2025 · Natalia A. Shnayder, Nikolai A. Pekarets, et al. · Journal of Clinical Medicine · 2
PDF
Personalized approach to prediction and prevention of haloperidol-induced metabolic syndrome
2025 · V. V. Grechkina, N. A. Shnayder · Personalized Psychiatry and Neurology · 2
Selective Serotonin Reuptake Inhibitors: a Safety Issue (systematic Review)
2025 · N. A. Shnayder, E. A. Makarov, et al. · Zabajkalʹskij medicinskij vestnik · 2
Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
2025 · N. A. Shnayder, V. V. Grechkina, et al. · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · 1
PDF
Monocyte-to-Lymphocyte Ratio Any Association with Metabolic Syndrome in Schizophrenia
2025 · N. V. Zakharova, A. V. Kidyaeva, et al. · Personalized Psychiatry and Neurology · 1
Selective serotonin reuptake inhibitors in pediatric neurology: a safety issue (systematic review)
2025 · N. A. Shnayder, E. A. Makarov, et al. · Russian Journal of Child Neurology · 1
PDF
Pharmacogenomics and pharmacometabolomics of levetiracetam in personalized neurotoxicity risk assessment
2026 · N. A. Shnayder, V. V. Bader, et al. · Epilepsy and Paroxysmal Conditions
PDF
The role of pharmacogenetic testing in predicting antipsychotic-induced adverse reactions
2026 · Regina F. Nasyrova, Alla V Kidyaeva, et al. · I P Pavlov Russian Medical Biological Herald
Роль нейропептида Y в развитии вальпроат-индуцированного расстройства пищевого поведения
· Шнайдер Наталья Алексеевна, Гречкина Виолетта Владимировна, et al. · CyberLeninK (CyberLeninka)
Роль микроРНК как регуляторов системного воспалительного ответа при метаболическом синдроме, индуцированном противоэпилептическими препаратами
· Шнайдер Наталья Алексеевна, Пекарец Николай Александрович, et al. · CyberLeninK (CyberLeninka)
Works count: 22
Citation count: 182
H-index: 7
I10-index: 2
Year
Topic
Type